CAS RN: 2359650-19-2

17,19-Metheno-1H,5H-cyclopent[5,6][1,4]oxazino[3,4-i]pyrazolo[4,3-f]pyrido[3,2-l][1,4,8,10]oxatriazacyclotridecin-14(11H)-one, 7-fluoro-2,3,3a,12,13,20a-hexahydro-11-methyl-, (3aS,11R,20aR)-

Product Availability

Choose a grade to view its available package options.

4 package records1 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250514 10mg Out of stock Inquiry
Batchno.20250506 25mg In stock Shanghai Inquiry
Batchno.20251104 50mg Out of stock Inquiry
Batchno.20250124 5mg Out of stock Inquiry
  • Product code: starshine_CAS2359650-19-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

2359650-19-2 / (3R,7S,17R)-12-fluoro-17-methyl-2,16-dioxa-8,14,19,23,24,26-hexazahexacyclo[22.3.1.03,7.08,27.010,15.021,25]octacosa-1(28),10(15),11,13,21(25),22,26-heptaen-20-one

Standard CAS: 2359650-19-2 Multi CAS: No

Basic Information

CAS
2359650-19-2
Multi CAS
No
Molecular Formula
C21H21FN6O3
Molecular Weight
424.400000
Exact Mass
424.165917
SMILES
C[C@@H]1CNC(=O)C2=C3N=C4C(=CN3N=C2)O[C@@H]5CCC[C@@H]5N4CC6=C(O1)N=CC(=C6)F
InChI
InChI=1S/C21H21FN6O3/c1-11-6-23-20(29)14-8-25-28-10-17-19(26-18(14)28)27(15-3-2-4-16(15)31-17)9-12-5-13(22)7-24-21(12)30-11/h5,7-8,10-11,15-16H,2-4,6,9H2,1H3,(H,23,29)/t11-,15+,16-/m1/s1
InChIKey
BYYQDEOVMILBQT-XFBWCDHKSA-N

Computed Properties

Structural Parameters

Heavy atom count
31
Aromatic heavy atom count
15
Fraction Csp3
0.43
H-bond acceptors
8
H-bond donors
1
Molar refractivity
107.84
TPSA
93.88

LogP / Solubility

WLOGP
2.09
MLOGP
1.87
XLogP3
1.8
Consensus LogP
1.92
Log S (ESOL)
-4.15
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.55
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.16
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.82

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
9

Get In Touch

Contact Us